… induction therapy. The aim of our study is to evaluate the proportion … patients with bacterial
infection among MM patients during the first 12 weeks of bortezomib-based induction therapy. …

… Sixty-six patients (25.5%) experienced severe infections … complication grades were those
of the National Cancer Institute … of severe bacterial infections was reduced by levofloxacin. …

… risk reduction of serious bacterial infections with prophylactic … , instituting prompt
bortezomib-based systemic therapy along … A study on real-world experience with …

… treatment factors such as use of bortezomib-based induction, … data from MD Anderson Cancer
Centre demonstrated a 2.1 … 90%) in clinical trials and in real-world settings[226-230]. The …

… 20% of MM patients at first relapse experience SREs, thus also … bacterial infections and
10-fold increased risk for viral … discrepancy between clinical trials and real-world MM patients …

… The BUMEL group more often experienced mucositis related … higher incidence of any
infections, especially of bacterial origin. … after triplet induction therapy in the East Asian population. …

… Adverse events were graded in accordance with the National Cancer Institute's Common …
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients …

… are required for all patients with myeloma-induced renal impairment. Mechanical …
Bortezomib-based regimens are the cornerstone of the management of patients with multiple …

… on sinopulmonary bacterial infections and the types of infections … Some investigators
recognize the pivotal role of real-world data … exposed frontline to bortezomib-based therapies (the …

… Induction therapy is the most crucial treatment in newly … can increase the risk of bacterial
infection, and bortezomib can … in NDMM patients receiving bortezomib-based therapy. …